Piperazine → HCID 21891565, compound

HRID 720352Notes

Reaction equation

HRID 720352 reaction equation
Cl[CH2:2][C:3]1[N:7]([CH3:8])[C:6]2[CH:9]=[C:10]([O:17][CH3:18])[C:11]([O:15][CH3:16])=[C:12]([O:13][CH3:14])[C:5]=2[N:4]=1.[NH:19]1[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1>>[CH3:8][N:7]1[C:6]2[CH:9]=[C:10]([O:17][CH3:18])[C:11]([O:15][CH3:16])=[C:12]([O:13][CH3:14])[C:5]=2[N:4]=[C:3]1[CH2:2][N:19]1[CH2:24][CH2:23][N:22]([CH2:2][C:3]2[N:7]([CH3:8])[C:6]3[CH:9]=[C:10]([O:17][CH3:18])[C:11]([O:15][CH3:16])=[C:12]([O:13][CH3:14])[C:5]=3[N:4]=2)[CH2:21][CH2:20]1

Participants

3

Reactant 2

HCID 4837PiperazineHCID 21891601HCID 21891601, compound

Product 1

HCID 21891565HCID 21891565, compound

Procedure

2-Chloromethyl-1-methyl-4,5,6-trimethoxy-benzimidazole (75 mg) and piperazine (10 mg) were reacted in the same manner as in Example 1 to obtain the title compound as a free base.

Sources & evidence

ORD record
ord-7272574f07844118903ca8c43f648b9f
Source dataset
uspto-grants-2006_11
Patent number
US07135473B2

Reaction notes

Loading…